{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T05:10:49Z","timestamp":1681449049742},"reference-count":0,"publisher":"The Medical Letter, Inc.","issue":"1675","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Lett Drugs Ther"],"abstract":"<jats:p>The FDA has approved Altuviiio (Sanofi), a von Willebrand Factor (VWF)-independent, recombinant factor VIII concentrate, for routine prophylaxis, on-demand treatment to control bleeding episodes, and perioperative management of bleeding in children and adults with hemophilia A. The manufacturer claims that Altuviiio, which was previously called efanesoctocog alfa, delivers normal to near-normal factor VIII levels for most of the week with once-weekly intravenous dosing.<\/jats:p>","DOI":"10.58347\/tml.2023.1675b","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T19:19:36Z","timestamp":1681413576000},"page":"67-68","source":"Crossref","is-referenced-by-count":0,"title":["Altuviiio \u2013 A Longer-Acting Factor VIII Product for Hemophilia A"],"prefix":"10.58347","volume":"65","author":[{"name":"Editors from The Medical Letter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37151","published-online":{"date-parts":[[2023,5,1]]},"container-title":["The Medical Letter on Drugs and Therapeutics"],"original-title":[],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T19:19:37Z","timestamp":1681413577000},"score":1,"resource":{"primary":{"URL":"https:\/\/secure.medicalletter.org\/TML-article-1675b"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":0,"journal-issue":{"issue":"1675","published-online":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.58347\/tml.2023.1675b","relation":{},"ISSN":["1523-2859"],"issn-type":[{"value":"1523-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]}}}